Product Information
ACITRETIN 17.5 MG CAPSULE is a generic product labeled by Alembic Pharmaceuticals Inc., priced at $5.4117 per EA under NDC 62332074230. Its NADAC has been published 82 times since Dec 4, 2024.
Strength
17.5 mg/1
Manufacturer
Alembic Pharmaceuticals Inc.NDC
62332074230
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACITRETINApproval Type
Generic (ANDA)
FDA Application
ANDA217774On Market Since
8/8/2024
Pharmacological Classes
Price Statistics
The NADAC for ACITRETIN 17.5 MG CAPSULE has been published 82 times since Dec 4, 2024, and over the history we have for it it has declined 59.0%. The table below summarizes its recorded NADAC range and movement.
| Current price | $5.4117 per EA |
|---|---|
| All-time high | $13.2128 (Dec 11, 2024) |
| All-time low | $4.9683 (Aug 20, 2025) |
| 52-week high | $7.9486 |
| 52-week low | $4.9683 |
| Median price | $7.2069 |
| Average price | $7.7850 |
| Largest weekly change | +55.6% (Jan 21, 2026) |
| Weeks tracked | 82 |
| Tracking since | Dec 4, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of ACITRETIN 17.5 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for ACITRETIN 17.5 MG CAPSULE, manufactured by Alembic Pharmaceuticals Inc., is $5.4117 per EA (NDC 62332074230), effective Jun 24, 2026.
How has the price of ACITRETIN 17.5 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for ACITRETIN 17.5 MG CAPSULE has declined 59.0%. It has been tracked across 82 weekly CMS publications since Dec 4, 2024.
What are the highest and lowest recorded NADAC prices for ACITRETIN 17.5 MG CAPSULE?
Since Dec 4, 2024, the NADAC for ACITRETIN 17.5 MG CAPSULE has ranged from a low of $4.9683 (Aug 20, 2025) to a high of $13.2128 (Dec 11, 2024), with a median of $7.2069 per EA.
Are there cheaper alternatives to ACITRETIN 17.5 MG CAPSULE?
2 NADAC-published products share the same active ingredient, strength, and dosage form as ACITRETIN 17.5 MG CAPSULE, but none are currently priced below it.
Who manufactures ACITRETIN 17.5 MG CAPSULE?
ACITRETIN 17.5 MG CAPSULE (NDC 62332074230) is labeled by Alembic Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification